“Monoclonal Antibody Therapy of T Cell Lymphoma: Single Agent Trials of Anti-CD2 (Siplizumab) and Anti-CD4 (Humax-CD4)”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 3, no. 1, June 2009, https://doi.org/10.4081/hmr.v3i1.532.